SCHEMBL23799233

SCHEMBL23799233

CN1CCCN(C2CCC(C#N)(c3cccc(Cl)c3)CC2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.51
DPP8 Q6V1X1 2/20 0.51
DPP9 Q86TI2 1/20 0.51
KMT2A Q03164 1/20 0.46
OPRM1 P35372 3/20 0.45
CCR1 P32246 2/20 0.40
CHRNA1 P02708 1/20 0.39
CHRNG P07510 1/20 0.39
CHRNB1 P11230 1/20 0.39
CHRNB2 P17787 1/20 0.39
SLC6A2 P23975 1/20 0.39
CHRNB4 P30926 1/20 0.39
SLC6A4 P31645 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CHRND Q07001 1/20 0.39
HRH3 Q9Y5N1 1/20 0.38
CYP2D6 P10635 1/20 0.38
OPRL1 P41146 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30179321 0.86 CYP2D6 (0.49) OPRM1CYP2D6OPRL1
SCHEMBL23778360 0.84 DPP4 (0.47) DPP4DPP8DPP9KMT2ASLC6A2
SCHEMBL5758344 0.81 KMT2A (0.66) KMT2AOPRM1OPRL1
SCHEMBL20066010 0.81 MEN1 (0.51) DPP4DPP8DPP9KMT2ASLC6A2
SCHEMBL5475853 0.79 KMT2A (0.75) KMT2AOPRM1SLC6A2SLC6A4SLC6A3
SCHEMBL23798663 0.79 CCR1 (0.41) KMT2AOPRM1CCR1OPRL1
SCHEMBL5475847 0.79 KMT2A (0.75) KMT2AOPRM1SLC6A2SLC6A4SLC6A3
SCHEMBL23798652 0.78 DPP4 (0.42) DPP4DPP8DPP9KMT2AOPRM1
SCHEMBL23778249 0.77 CYP2D6 (0.43) DPP4DPP8DPP9KMT2ACYP2D6
SCHEMBL23798593 0.76 CYP2D6 (0.47) DPP4DPP8DPP9KMT2ACCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3526207-B1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LTD (GB) 2021-09-08 EP disclosed